{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:37:39Z","timestamp":1747172259376,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","whijournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Women's Health Issues"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.whi.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T21:14:16Z","timestamp":1703106856000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mifepristone Use Among Obstetrician-Gynecologists in Massachusetts: Prevalence and Predictors of Use"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6323-3796","authenticated-orcid":false,"given":"Emily","family":"Newton-Hoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Janiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-8115","authenticated-orcid":false,"given":"Sara","family":"Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.whi.2023.11.007_bib1","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/AOG.0000000000004176","article-title":"Increasing access to abortion: ACOG Committee Opinion, Number 815","volume":"136","year":"2020","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.whi.2023.11.007_bib2","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG Practice Bulletin No. 200: Early pregnancy loss","volume":"132","year":"2018","journal-title":"Obstetrics and Gynecology"},{"issue":"8","key":"10.1016\/j.whi.2023.11.007_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jama.2023.13628","article-title":"Trends in the use of mifepristone for medical management of early pregnancy loss from 2016 to 2020","volume":"330","author":"Boos","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.whi.2023.11.007_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s10995-021-03338-6","article-title":"\u201cNo one does this for the money or lifestyle\u201d: Abortion providers\u2019 perspectives on factors affecting workforce recruitment and retention in the southern United States","volume":"26","author":"Chowdhary","year":"2022","journal-title":"Maternal and Child Health Journal"},{"issue":"10253","key":"10.1016\/j.whi.2023.11.007_bib6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(20)31788-8","article-title":"Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): A randomised, double-blind, placebo-controlled trial","volume":"396","author":"Chu","year":"2020","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.whi.2023.11.007_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/ACM.0000000000000679","article-title":"Health systems innovation at academic health centers: Leading in a new era of health care delivery","volume":"90","author":"Ellner","year":"2015","journal-title":"Academic Medicine"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/OGX.0b013e318286f0aa","article-title":"Sex differences among obstetrician-gynecologists: A review of survey studies","volume":"68","author":"Farrow","year":"2013","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000977","article-title":"Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: A randomized controlled trial","volume":"126","author":"Goldberg","year":"2015","journal-title":"Obstetrics & Gynecology"},{"issue":"7","key":"10.1016\/j.whi.2023.11.007_bib12","first-page":"493","article-title":"Barriers and enablers to becoming abortion providers: The reproductive health program","volume":"44","author":"Greenberg","year":"2012","journal-title":"Family Medicine"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000003110","article-title":"Induced abortion provision among a national sample of obstetrician\u2013gynecologists","volume":"133","author":"Grossman","year":"2019","journal-title":"Obstetrics & Gynecology"},{"year":"2022","series-title":"Medication abortion now accounts for more than half of all US abortions","key":"10.1016\/j.whi.2023.11.007_bib14"},{"journal-title":"Guttmacher Institute","article-title":"State facts about abortion: Massachusetts","year":"2022","key":"10.1016\/j.whi.2023.11.007_bib41"},{"issue":"7","key":"10.1016\/j.whi.2023.11.007_bib15","first-page":"527","article-title":"Pregnancy options counseling and abortion referrals among US primary care physicians: Results from a national survey","volume":"49","author":"Holt","year":"2017","journal-title":"Family Medicine"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/14656560903535880","article-title":"Mifepristone: Pharmacology and clinical impact in reproductive medicine, endocrinology and oncology","volume":"11","author":"Im","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"author":"Izrael","key":"10.1016\/j.whi.2023.11.007_bib17"},{"issue":"6","key":"10.1016\/j.whi.2023.11.007_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: A randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41372-019-0542-3","article-title":"Obstetrician-gynecologists\u2019 practices and attitudes on substance use screening during pregnancy","volume":"40","author":"Ko","year":"2020","journal-title":"Journal of Perinatology: Official Journal of the California Perinatal Association"},{"issue":"5","key":"10.1016\/j.whi.2023.11.007_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.contraception.2020.12.009","article-title":"Twenty years of the Ryan residency training program in abortion and family planning","volume":"103","author":"Landy","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.whi.2023.11.007_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.contraception.2022.08.001","article-title":"Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study","volume":"117","author":"Lee","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.whi.2023.11.007_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7812\/TPP\/19.217","article-title":"Knowledge, attitudes, and perceptions about medicolegal education: A survey of OB\/GYN residents","volume":"24","author":"Mathew","year":"2020","journal-title":"The Permanente Journal"},{"issue":"1","key":"10.1016\/j.whi.2023.11.007_bib25","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1097\/01.AOG.0000825716.77939.40","article-title":"Medication management of early pregnancy loss: The impact of the U.S. Food and Drug Administration risk evaluation and mitigation strategy [A289]","volume":"139","author":"Neill","year":"2022","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.whi.2023.11.007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110108","article-title":"Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use","volume":"126","author":"Neill","year":"2023","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1363\/psrh.12237","article-title":"Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB\/GYNS in Massachusetts, USA","volume":"55","author":"Neill","year":"2023","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"10.1016\/j.whi.2023.11.007_bib28","doi-asserted-by":"crossref","DOI":"10.2196\/42582","article-title":"The next infodemic: Abortion misinformation","volume":"25","author":"Pagoto","year":"2023","journal-title":"Journal of Medical Internet Research"},{"issue":"1","key":"10.1016\/j.whi.2023.11.007_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.contraception.2021.03.022","article-title":"Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois","volume":"104","author":"Rasmussen","year":"2021","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.whi.2023.11.007_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jme.2010.040782","article-title":"Obstetrician-gynaecologists\u2019 opinions about conscientious refusal of a request for abortion: Results from a national vignette experiment","volume":"37","author":"Rasinski","year":"2011","journal-title":"Journal of Medical Ethics"},{"key":"10.1016\/j.whi.2023.11.007_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2022.01.017","article-title":"Exploring the impact of mifepristone\u2019s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics","volume":"109","author":"Razon","year":"2022","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.whi.2023.11.007_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/AOG.0000000000002265","article-title":"Geographic comparison of women in academic obstetrics and gynecology department-based leadership roles","volume":"130","author":"Ricciotti","year":"2017","journal-title":"Obstetrics and Gynecology"},{"issue":"23","key":"10.1016\/j.whi.2023.11.007_bib33","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss","volume":"378","author":"Schreiber","year":"2018","journal-title":"New England Journal of Medicine"},{"year":"2015","series-title":"Community health centers: A 2013 profile and prospects as ACA implementation proceeds","author":"Shin","key":"10.1016\/j.whi.2023.11.007_bib34"},{"issue":"3","key":"10.1016\/j.whi.2023.11.007_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/AOG.0b013e31822ad973","article-title":"Abortion provision among practicing obstetrician\u2013gynecologists","volume":"118","author":"Stulberg","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.whi.2023.11.007_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2021.05.001","article-title":"The disproportionate burdens of the mifepristone REMS","volume":"104","author":"Thompson","year":"2021","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.whi.2023.11.007_bib37","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008","volume":"60","author":"Ventura","year":"2012","journal-title":"National Vital Statistics Reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System"},{"issue":"2","key":"10.1016\/j.whi.2023.11.007_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/AOG.0000000000004832","article-title":"Projected implications of overturning Roe v Wade on abortion training in U.S. obstetrics and gynecology residency programs","volume":"140","author":"Vinekar","year":"2022","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.whi.2023.11.007_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/2633489520959072","article-title":"The role of clinical champions in facilitating the use of evidence-based practice in drug and alcohol and mental health settings: A systematic review","volume":"1","author":"Wood","year":"2020","journal-title":"Implementation Research and Practice"},{"issue":"5","key":"10.1016\/j.whi.2023.11.007_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1370\/afm.3006","article-title":"ExPAND mifepristone: Medical management of miscarriage and abortion in FQHCs","volume":"21","author":"Wu","year":"2023","journal-title":"Annals of Family Medicine"}],"container-title":["Women's Health Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1049386723002086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1049386723002086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T16:30:40Z","timestamp":1711384240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1049386723002086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1049386723002086"],"URL":"https:\/\/doi.org\/10.1016\/j.whi.2023.11.007","relation":{},"ISSN":["1049-3867"],"issn-type":[{"type":"print","value":"1049-3867"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mifepristone Use Among Obstetrician-Gynecologists in Massachusetts: Prevalence and Predictors of Use","name":"articletitle","label":"Article Title"},{"value":"Women's Health Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.whi.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Jacobs Institute of Women's Health, George Washington University. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}